Objective: The aim of the present study was to evaluate the therapeutic potency of an electrotherapy of striated ischiocavernous muscles in patients with erectile dysfunction. Patients and Methods: Transcutaneous electrostimulation of striated ischiocavernous muscles by self-adhesive penile or perineal skin electrodes was performed in 48 patients with erectile dysfunction. 6/48 patients (R) responded to intracavernous pharmacotherapy while 42/48 (NR) did not show significant penile rigidity even to intracavernous papaverine/phentolamine/PGE1 triple drug medication. Results: Within the observation time of 3 months, 10/48 patients dropped out. 22/38 patients reported a penile rigidity for sufficient sexual intercourse whereby 3/22 NR required additional intracavernous pharmacotherapy. Penile rigidity could be objectivated by triple drug medicaton in 12/14 NR after ischiocavernous muscle stimulation (EIS) therapy. 5/6 R were treated successfully for premature erection loss. During EIS treatment neither discomfort nor complications could be observed. Conclusion: Transcutaneous electrostimulation of ischiocavernous muscles is a new, noninvasive therapy for the improvement of penile rigidity. The clinical results underline the importance of the striated ischiocavernous muscles for penile rigidity.

1.
Porst H, van Ahlen H: Dynamic cavernosography and corpus cavernosum pharma testing in the diagnostics of the erectile dysfunction. Urologe A 1987;26:152–157.
2.
Aboseif R, Baskin LS, Yen TS, Lue TF: Congenital defect in sinusoidal smooth muscles: A cause of organic impotence. J Urol 1992;148:58–60.
3.
Wespes E, Sattar AA, Golarian J, Wery D, Daoud N, Schulmann CC: Corporeal veno-occlusive dysfunction: Predominantly intercavernous muscular pathology. J Urol 1997;157:1678–1680.
4.
Derouet H: Venoocclusive Dysfunction as Special Form of the Erectile Dysfunction: Clinical and Experimental Examinations. Aachen, Shaker, 1998.
5.
Stief CG, Truss MC, Schultheiss D, Becker AJ, Jonas U: Long-term outcome of penile venous surgery in 121 patients with venoocclusive dysfunction. Int J Impot Res 1996;8:154.
6.
Albers P, Mueller SC, Witsch U, Schild H: The therapy of the erectile dysfunction with venous leakage – Long-term results of the penis vessels embolism. Aktuel Urol 1993;24:205–208.
7.
Derouet H, Zehl U: The treatment of the erectile dysfunction by vacuum pumps. Urologe A 1993;32:312–315.
8.
Lavoisier P, Courtois F, Bornes D, et al: Correlation between ischiocavernous pressure and contraction of the ischiocavernous muscle in man. J Urol 1986;136:936–939.
9.
Michal V, Simana J, Rehak J, Masin J: Haemodynamics of erection in man. Physiol Bohemoslov 1983;32:497–499.
10.
Claes H, Baert L: Pelvic floor exercise versus surgery in the treatment of impotence. Br J Urol 1993;71:52–57.
11.
Claes H, van Hove J, van deVoorde W, Lauweryns J, De Roo E, Lysens R, Baert L: Pelvic-perineal rehabilitation for dysfunctioning erections – A clinical and anatomophysiologic study. Int J Impot Res 1993;5:13–26.
12.
Claes H, Bijnens B, Baert L: The hemodynamic influence of the ischiocavernosus muscles on erectile function. J Urol 1996;156:986–990.
13.
Trimble MH, Enoka RM: Mechanisms underlying the training effects associated with neuromuscular electrical stimulation. Phys Ther 1991;71:273–281.
14.
Stief CG, Baehren W: Intrakavernöse Pharmakontestung-SKAT-Test; in Baehren W, Altwein JE (eds): Impotenz. Stuttgart, Thieme, 1988, pp 65–71.
15.
Karacan I, Aslan C, Hirshkowitz M: Erectile mechanism in men. Science 1983;220:1080.
16.
Beckett SD, Hudson RS, Walker DF, Vachon RI, Reynolds TM: Corpus cavernosum penis pressure and external penile muscle activity during erection in the goat. Biol Reprod 1972;7:359.
17.
Stief CG, Weller E, Noack T, Djamilian MH, Meschi M, Truss M, Jonas U: Functional electromyostimulation of the corpus cavernosum penis (FEMCC). Urologe A 1996;35:321–325.
18.
Benton LA, Baker LL, Bowman BR, Waters RL: Funktionelle Elektrostimulation. Darmstadt, Steinkopff, 1983, pp 20–37.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.